CHEMICAL/BIOLOGICAL DEFENSE (ATD)
Abstract
This program element (PE) demonstrates technologies that enhance the ability of U.S. forces to deter, defend against, and survive Chemical, Biological, and Radiological (CBR) warfare. The PE funds advanced technology development for Joint Service and Service-specific requirements in both medical and physical sciences CBR defense areas. In the physical sciences area, Project CB3 focuses on demonstrations of CB defense technologies, including biological detection, chemical detection, information system technology for hazard prediction and systems performance, and protection, and decontamination. The Project continues to pursue solutions against traditional agents. All non-traditional agent (NTA)-dedicated research (both medical and non-medical) is consolidated in Project NT3. This Project includes NTA chemical diagnostics, medical pretreatments, therapeutics, detection, and protection and hazard mitigation. The medical program in Project TM3, aims to produce biological diagnostic assays and reagents, diagnostic device platforms, pretreatments and therapeutics for bacterial, viral, and toxin threats as well as for chemical threats, and medical devices, as countermeasures for CBR threat agents. Specific areas of medical investigation include: prophylaxis, pretreatment, antidotes and therapeutics, personnel and patient decontamination, and medical management of casualties. Project TT3, Techbase Technology Transition, pursues efforts to enhance military operational capability, concepts of operation, WMD elimination, and hazard mitigation following a biological warfare or chemical warfare attack. The PE is dedicated to conducting proof-of-principle field demonstrations, and testing system-specific technologies to meet specific military needs. Work conducted under this PE will transition to and will provide risk reduction for PE 0603884BP/PE 0604384BP activities.
Document Details
- Document Type
- R2 Budgetary Justification
- Publication Date
- Oct 01, 2015
- Source ID
- 0603384BP_3_0400_PB_2015
- Change Summary Explanation
- Funding: FY13: Reductions of $14.8M impacted efforts supporting threat agent sciences, medical countermeasures and diagnostics device development. FY14: Reductions of $26.0M delay key physical and medical program technology development efforts in threat agent sciences, early warning/remote detection, biosurveillance informatics, medical countermeasure pretreatments, diagnostics, and hazard mitigation capabilities. FY15: Reductions of $22.0M impact medical countermeasure candidates, diagnostic device technology evaluations, and brassboard prototypes supporting genomic sequencing capabilities. Schedule: N/A Technical: N/A
- Service Agency Name
- Chemical and Biological Defense Program
Related Documents
- Child Project: CHEMICAL BIOLOGICAL DEFENSE (ATD)
- Child Accomplishment: 1) Biosurveillance (BSV)
- Child Accomplishment: 2) Detection
- Child Accomplishment: 3) Hazard Prediction
- Child Accomplishment: 4) Data Analysis
- Child Accomplishment: 5) Operational Effects
- Child Accomplishment: 6) Filtration
- Child Accomplishment: 7) Respirators
- Child Accomplishment: 8) Fabrics
- Child Accomplishment: 9) Decontamination
- Child Accomplishment: 10) Test and Evaluation (T&E)
- Child Project: TECHBASE NON-TRADITIONAL AGENTS DEFENSE (ATD)
- Child Accomplishment: 1) Diagnostics - Medical
- Child Accomplishment: 2) Pretreatments - Medical
- Child Accomplishment: 3) Therapeutics - Medical
- Child Accomplishment: 4) Detection
- Child Accomplishment: 5) Modeling & Simulation
- Child Accomplishment: 6) Air Purification
- Child Accomplishment: 7) Percutaneous Protection
- Child Accomplishment: 8) Decontamination
- Child Accomplishment: 9) Test & Evaluation
- Child Project: TECHBASE MED DEFENSE (ATD)
- Child Accomplishment: 1) Assays and Reagents
- Child Accomplishment: 2) Bacterial Therapeutics
- Child Accomplishment: 3) Bacterial/Toxin Vaccines
- Child Accomplishment: 4) Bacterial/Toxin Vaccines
- Child Accomplishment: 5) Biosurveillance
- Child Accomplishment: 6) Chemical Diagnostics
- Child Accomplishment: 7) Diagnostic Device Platforms
- Child Accomplishment: 8) Medical Countermeasures Initiative
- Child Accomplishment: 9) Multiagent Medical Countermeasures
- Child Accomplishment: 10) Nerve Agent Pretreatments
- Child Accomplishment: 11) Neurologic Therapeutics
- Child Accomplishment: 12) Next Generation Diagnostics
- Child Accomplishment: 13) Toxin Therapeutics
- Child Accomplishment: 14) Vaccine Platforms and Research Tools
- Child Accomplishment: 15) Viral Therapeutics
- Child Accomplishment: 16) Viral Vaccines
- Child Project: TECHBASE TECHNOLOGY TRANSITION
- Child Accomplishment: 1) Experiment & Technology Demonstrations